Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2016

View Archived Issues

Avacta enters research collaboration with Memorial Sloan Kettering Cancer Center

NIH funding to support Qrono's development of QARRUS platform

Nitto Denko initiates phase I trials in Japan for sublingual seasonal influenza HA vaccine

Celgene offers overview of third quarter 2016

[177-Lu]Pentixather-based endoradiotherapy in xenograft models of leukemia

Umecrine Cognition reports phase I results on GR-3027

Researchers present phase II data for maribavir for treatment of cytomegalovirus infections

Aclaris Therapeutics submits IND to begin study of ATI-50001

Rebiotix's RBX-2660 effective in phase IIb trial for recurrent Clostridium difficile infection

AbbVie presents key events from the third quarter 2016

Intravenous zanamivir shows potential for severe influenza in pediatric patients

ProMIS identifies five antibody candidates with desired target profile for Alzheimer's

Albireo and Biodel complete share exchange to form combined company

KemPharm appeals FDA's CRL for Apadaz

Immunovaccine's DepoVax-formulated neoepitopes show promise in preclinical studies

ReVance Therapeutics initiates phase II trial of RT-002 in plantar fasciitis

Astellas Pharma recaps key events of second quarter of fiscal 2016

Actelion obtains exclusive option to in-license vamorolone

Bio-Path Holdings' BP-1001 awarded orphan drug status from EMA

Prana offers regulatory update on PBT-2 for Huntington's disease

ARTES Biotechnology and BioSun Pharmed collaborate on HPV vaccine in Iran

Takeda offers pipeline update for second quarter of fiscal 2016

Immunocytokine cergutuzumab amunaleukin accumulation evaluated with PET in phase I study

Galapagos describes novel GPR84 antagonists

Innocoll updates progress of Cogenzia, Xaracoll and Collaguard programs

Nordic Nanovector announces progress of phase I/II trial of Betalutin

FORMA Therapeutics discovers new histone deacetylase inhibitors

Committee recommends continuation of Atox Bio's phase III ACCUTE study

Merck KGaA presents novel activin receptor-like kinase inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...